The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade.
News|Podcasts|February 24, 2023
Rising sea level: The transportation of pharmaceuticals by sea continues to gain momentum in the quest for greater supply chain resilience
Author(s)Klinge
When shipping pharmaceuticals internationally, the decision of ocean shipping versus air shipping might seem obvious if the speed of air shipping is the only factor at play when sending sensitive medical supplies and drugs. For the last several years, however, more companies have decided to embrace ocean shipping as a means of delivering their medicines. Industry experts Alan Kennedy and Allan Klinge discuss how, with more cold chain control, a lower carbon footprint and lower costs, ocean-going vessels often have clear advantages over air freight.
Advertisement
Advertisement
Related to this article
Rebate delays could force 340B hospitals to pay upfront and wait months for credit, distorting drug spend on the books. Valerie Bandy, PharmD, of Tecsys explains the fallout.
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
DSCSA data exchange has matured into daily operations, but the coming NDC-12 shift and a national licensure standard add new work streams before old ones are fully settled.
Liberty Dewey of Cardinal Health breaks down the NDC-12 transition timeline, the four work streams driving it and why the biggest risk sits in trading partner handoffs.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
An FTC settlement moved one PBM aggregator onshore, but manufacturers still lack contract-level clarity on what affiliated fees actually buy.
Simvera PSP applies queueing science so manufacturers can test the cost and patient impact of hub staffing decisions before locking them in.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
White House Extends MFN Pricing to Every State Medicaid Program
2
Pharma Pulse: Independent Pharmacies Sue Express Scripts, Novo Taps Anthropic, Pharma Joins Clean Heat
3
How Rebate Timing Distorts a Pharmacy's 340B Books
4
The PBM Entity No Pharmaceutical Company Directly Contracted With
5